Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is ...

Welireg's sNDA for advanced PPGL treatment is under FDA priority review, potentially becoming the first U.S. therapy for this condition. The LITESPARK-015 trial supports the sNDA with ORR and DOR data ...

WAYZATA, MN / ACCESS Newswire / February 3, 2025 / Mill City Ventures III, Ltd. (NASDAQ:MCVT) announced today that it has entered into a Security Agreement with Mustang Funding, LLC. Under the ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private ...

Days into Oval Office, Donald Trump took major decisions including imposing 25% Tariffs on all Mexican and Canadian goods. As the tariffs war escalated between the three countries, Canada and Mexico ...

Merck, known as MSD outside of the United States and Canada, announced the US Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application (sNDA) seeking ...

Metairie-based SRSA Commercial Real Estate has launched SRSA Residential.

Features of priciest Phoenix-area homes to sell in January include views of Camelback and Mummy mountains, a billiard room ...